concomitant insulin use and use of non-insulin anti-diabetic medication. Both bivariate analyses and multivariate regression analyses were applied to examine whether there were differences in the ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

"This can provide some guidance in the choice of anti-diabetic medications for diabetes ... "We know that GLP-1 drugs treat insulin resistance, which has a positive impact on the whole body ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

“Your drug has a generic” that may cost less. In the case of insulin, if the generic is covered, it won’t cost less but chances are the plan will save money. And that can be a factor in what ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

New research presented at the ACG Annual Meeting suggests that GLP-1RAs lower the risk of pancreatic cancer in patients with ...

latest HbA 1c-value), use of insulin and non-insulin anti-diabetic medication. In total, 490 GP offices were contacted by letter (72), telephone (146) or online (272), and 86 endocrinological ...